Business Standard

Saturday, December 21, 2024 | 09:15 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

'Rules are different for public labs as compared to private labs'

Ameera Shah, promoter and managing Director of Metropolis Healthcare, says private labs have been at the forefront of medical testing.

Ameera Shah, Promoter and Managing Director, Metropolis Healthcare
Premium

Ameera Shah, Promoter and MD of Metropolis says it is a strong institution with a healthy balance sheet and good cash reserves.

Sohini Das Mumbai
Private laboratory chain Metropolis Healthcare fears a "negative influence" if state governments cap the price on reverse trasncription polymerase chain reaction (RT-PCR) test to detect Covid-19 far below the originally proposed price of Rs 4,500 per test. Ameera Shah, promoter and managing Director of Metropolis Healthcare, tells Sohini Das in an email interview India must scale up testing for coronavirus.

There is a tendency to cap prices for tests. How do you see that?

Currently, there are three approved technologies for conducting the confirmatory test for COVID 19: TruNAT, GeneXpert (CBNAAT) and RT PCR test. Both TruNAT and GeneXpert incur

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in